Geniposide, a Novel Agonist for GLP-1 Receptor, Prevents PC12 Cells from Oxidative Damage via MAP Kinase Pathway
Abstract
Alzheimer's disease (AD) is the most common form of dementia. Glucagon-like peptide-1 (GLP-1) gives a new genre in therapeutic targets for intervention in AD with its neurotrophic and neuroprotective functions. In previous work, we identified that geniposide is a novel agonist for GLP-1 receptor, which shows neurotrophic characteristics to induce the neuronal differentiation of PC12 cells. The aim of this study is to determine whether geniposide prevents neurons from oxidative damage, and to explore its signaling pathways. The results demonstrated that geniposide increased the expression of anti-apoptotic proteins, including Bcl-2 and heme oxygenase-1 (HO-1), to antagonize the oxidative damage in PC12 cells induced by hydrogen peroxide. LY294002 (a PI3K inhibitor) inhibited the effect of geniposide increasing of Bcl-2 level by activation of MAPK, MEK and c-Raf phosphorylation in hydrogen peroxide treated PC12 cells. U0126 (a selective inhibitor of MEK) also attenuated the enhancement of geniposide on Bcl-2 level by inhibiting the phosphorylation of p90RSK in the hydrogen peroxide treated PC12 cells. All these data demonstrate that geniposide, an agonist for GLP-1 receptor, regulates expression of anti-oxidative proteins including HO-1 and Bcl-2 by activating the transcriptor of p90RSK via MAPK signaling pathway in PC12 cells.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Geniposide protects PC12 and SH-SY5Y cells from oxidative damage and apoptosis by modulating MAPK signaling, caspases, and increasing SOD and GPx.
“geniposide has been demonstrated to protect PC12 and SH-SY5Y cells from oxidative damage and apoptotic processes, by modulating the MAPK signaling pathways and caspases expression and by increasing the levels of SOD and GPx (Liu et al., 2006; Liu et al., 2007; Yin et al., 2010a; Yin et al., 2010b; Sun et al., 2013)”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Liu et al., 2007
Cites
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,248 · see citing works
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · see citing works
Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · see citing works
Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
Perry, T., Haughey, N. J., Mattson, M. P., Egan, J. M., & Greig, N. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037481 · Cited by 380 · see citing works
Perry, T., Lahiri, D. K., Sambamurti, K., Chen, D., Mattson, M. P., Egan, J. M., & Greig, N. H. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10611 · Cited by 347 · see citing works
Perry, T., Lahiri, D., Chen, D., Zhou, J., Shaw, K., Egan, J., & Greig, N. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.958 · Cited by 306 · see citing works
Vitamin E and Alzheimer disease: the basis for additional clinical trials
Grundman, M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.630s · Cited by 267 · see citing works
Counts, S., & Mufson, E. J. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.4.263 · Cited by 223 · see citing works
Chen, Z.-H., Saito, Y., Yoshida, Y., Sekine, A., Noguchi, N., & Niki, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508556200 · Cited by 197 · see citing works
Apelt, J., Bigl, M., Wunderlich, P., & Schliebs, R. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.006 · Cited by 175 · see citing works
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter
Larsen, P. J., & Holst, J. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.026 · Cited by 104 · see citing works
GLP-1 based therapy for type 2 diabetes
Arulmozhi, D. K., & Portha, B. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.01.003 · Cited by 101 · see citing works
Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease
Castellani, R. J., Honda, K., Zhu, X., Cash, A., Nunomura, A., Perry, G. L., & Smith, M. A. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.01.002 · Cited by 97 · see citing works
Class II G Protein-Coupled Receptors and Their Ligands in Neuronal Function and Protection
Martin, B., de Maturana, R. L., Brenneman, R., Walent, T., Mattson, M. P., & Maudsley, S. R. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:003 · Cited by 89 · see citing works
Neurotrophic Property of Geniposide for Inducing the Neuronal Differentiation of PC12 Cells
Liu, J., Zheng, X., Yin, F., Hu, Y., Guo, L., Deng, X., Chen, G., Jiajia, J., & Zhang, H. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2006.08.009 · Cited by 86 · see citing works
Self-citationGibson, G. E., Park, L. C. H., Zhang, H., Sorbi, S., & Calingasan, N. Y. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07819.x · Cited by 85 · see citing works
Yamazaki, M., Chiba, K., & Mohri, T. (1996) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.19.791 · Cited by 80 · see citing works
Estrogen as a treatment for Alzheimer disease.
Cosgrove, D. (2000) · PubMed · Cited by 62 · see citing works
Estrogen as a Treatment for Alzheimer Disease
Fontanarosa, P. B., & Cosgrove, D. (2000) · JAMA · doi:10.1001/jama.284.3.307 · Cited by 57 · see citing works
Satoh, F., Beak, S. A., Small, C. J., Falzon, M., Ghatei, M. A., Bloom, S. R., & Smith, D. M. (2000) · Endocrinology · doi:10.1210/endo.141.4.7420 · Cited by 53 · see citing works
Kuo, W., Chou, F., Young, S.-C., Chang, Y., & Wang, C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.02.013 · Cited by 53 · see citing works
Lee, P., Lee, J., Choi, S. Y., Lee, S. E., Lee, S., & Son, D. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.174 · Cited by 52 · see citing works
CRE‐mediated gene transcription in the peri‐infarct area after focal cerebral ischemia in mice
Sugiura, S., Kitagawa, K., Omura‐Matsuoka, E., Sasaki, T., Tanaka, S., Yagita, Y., Matsushita, K., Storm, D. R., & Hori, M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10881 · Cited by 45 · see citing works
Montrose‐Rafizadeh, C., Wang, Y., Janczewski, A. M., Henderson, T. E., & Egan, J. M. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00079-8 · Cited by 34 · see citing works
An unconventional hypothesis of oxidation in alzheimer's disease: intersections with excitotoxicity
Barger, S. W. (2004) · Frontiers in bioscience · doi:10.2741/1481 · Cited by 22 · see citing works
Stellenwert von Ginkgo biloba in der Behandlung der Alzheimer-Demenz
Loew, D. (2002) · Wiener Medizinische Wochenschrift · doi:10.1046/j.1563-258x.2002.02065.x · Cited by 11 · see citing works
Neuritogenesis of Herbal Geniposide-Related Compounds in PC12h Cells
Chiba, K., Yamazaki, M., Kikuchi, M., Machida, K., & Kikuchi, M. (2006) · Eisei kagaku · doi:10.1248/jhs.52.743 · Cited by 5 · see citing works
GLP-1 et détection cérébrale du glucose, un relais de régulation de l’homéostasie glucidique
Burcelin, R., Cani, P. D., & Knauf, C. (2006) · médecine/sciences · doi:10.1051/medsci/2006223237 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
de la Monte, S. M. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015037 · Cited by 446 · see citing works
Butterfield, D. A., Di Domenico, F., & Barone, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.010 · Cited by 402 · see citing works
de la Monte, S. M. (2012) · Drugs · doi:10.2165/11597760-000000000-00000 · Cited by 265 · see citing works
Salcedo, I., Tweedie, D., Li, Y., & Greig, N. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01971.x · Cited by 263 · see citing works
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review
Dinda, B., Dinda, M., Kulsi, G., Chakraborty, A., & Dinda, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.009 · Cited by 175 · see citing works
Liu, J., Yin, F., Guo, L., Deng, X., & Hu, Y. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2008.25 · Cited by 140 · see citing works
Self-citationPotential role of genipin in cancer therapy
Shanmugam, M. K., Shen, H., Tang, F. R., Arfuso, F., Rajesh, M., Wang, L., Kumar, A. P., Bian, J., Goh, B. C., Bishayee, A., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.05.007 · Cited by 138 · see citing works
Shan, M., Yu, S., Yan, H., Guo, S., Xiao, W., Wang, Z., Li, Z., Ding, A., Wu, Q., & Li, S. (2017) · Molecules · doi:10.3390/molecules22101689 · Cited by 137 · see citing works
Kim, D. S., Choi, H.-I., Wang, Y., Luo, Y., Hoffer, B. J., & Greig, N. H. (2017) · Cell Transplantation · doi:10.1177/0963689717721234 · Cited by 136 · see citing works
Vrang, N., & Larsen, P. J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.07.003 · Cited by 134 · see citing works
Kimura, R., Okouchi, M., Fujioka, H., Ichiyanagi, A., Ryuge, F., Mizuno, T., Imaeda, K., Okayama, N., Kamiya, Y., Asai, K., et al. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.025 · Cited by 129 · see citing works
GLP-1’s role in neuroprotection: a systematic review
Erbil, D., Eren, C. Y., Demirel, Ç., Küçüker, M. U., Solaroğlu, İ., & Eser, H. Y. (2019) · Brain Injury · doi:10.1080/02699052.2019.1587000 · Cited by 128 · see citing works
Zhang, A., Sun, H. J., Yuan, Y., Sun, W., Jiao, G., & Wang, X. (2011) · Fitoterapia · doi:10.1016/j.fitote.2011.07.014 · Cited by 116 · see citing works
Thuan, D. T. B., Zayed, H., Eid, A. H., Abou-Saleh, H., Nasrallah, G. K., Mangoni, A. A., & Pintus, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01985 · Cited by 114 · see citing works
Jiang, Y., Chang, G., Wang, Y., Zhang, D., Cao, L., & Liu, J. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445634 · Cited by 112 · see citing works
Self-citationEmerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
Gouda, N., Elkamhawy, A., & Cho, J. (2022) · Biomedicines · doi:10.3390/biomedicines10020371 · Cited by 94 · see citing works
Habtemariam, S., & Lentini, G. (2018) · Biomedicines · doi:10.3390/biomedicines6020039 · Cited by 104 · see citing works
Yaribeygi, H., Rashidy-Pour, A., Atkin, S. L., Jamialahmadi, T., & Sahebkar, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118645 · Cited by 96 · see citing works
Lv, C., Wang, L., Liu, X., Yan, S., Yan, S. S., Wang, Y., & Zhang, W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.019 · Cited by 93 · see citing works
Hong, J.-T., Yen, J.-H., Wang, L., Lo, Y., Chen, Z., & Wu, M. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.02.014 · Cited by 93 · see citing works
A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases
Wang, Y., Jiang, S., Wang, H., & Bie, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189478 · Cited by 91 · see citing works
Liu, H., Chen, Y., Li, F., & Zhang, H. (2012) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2012.723203 · Cited by 90 · see citing works
Chen, Z., Lu, Y., Du, S., Shang, K.-X., & Cai, C.-B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.017 · Cited by 79 · see citing works
Geniposide and its iridoid analogs exhibit antinociception by acting at the spinal GLP-1 receptors
Gong, N., Fan, H. J., Ma, A., Xiao, Q., & Wang, Y. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.04.007 · Cited by 78 · see citing works
Wang, J., Zhang, Y., Liu, R., Li, X., Cui, Y., & Qu, L. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0536 · Cited by 74 · see citing works
Piccialli, I., Tedeschi, V., Caputo, L., D’Errico, S., Ciccone, R., De Feo, V., Secondo, A., & Pannaccione, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.876614 · Cited by 73 · see citing works
Deng, R., Wu, H., Yan, W., & Mengdie, W. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113958 · Cited by 69 · see citing works
Wang, J., Hou, J., Zhang, P., Li, D., Zhang, C., & Liu, J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0852-8 · Cited by 67 · see citing works
Self-citationYin, F., Liu, J., Zheng, X., Guo, L., & Xiao, H. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1841 · Cited by 67 · see citing works
Self-citationAntithrombotic activities of aqueous extract fromGardenia jasminoidesand its main constituent
Zhang, H., Liu, H., Ming, Y., & Wei, S. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.717088 · Cited by 65 · see citing works
Ishii, T., & Warabi, E. (2019) · Antioxidants · doi:10.3390/antiox8030069 · Cited by 62 · see citing works
Guo, L., Xia, Z., Gao, X. C., Yin, F., & Liu, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.146 · Cited by 61 · see citing works
Self-citationZheng, X.-W., Yang, W.-T., Chen, S., Xu, Q., Shan, C.-S., Zheng, G., & Ruan, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5058609 · Cited by 60 · see citing works
Self-citationFan, H. J., Gong, N., Li, T., Ma, A., Wu, X., Wang, M., & Wang, Y. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12895 · Cited by 60 · see citing works
Li, N., Li, L., Wu, H., & Zhou, H. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7480512 · Cited by 59 · see citing works
Therapeutic targets of brain insulin resistance in sporadic Alzheimer s disease
de la Monte, S. M. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e482 · Cited by 56 · see citing works
Jeng-Dian, S., Yen, J.-H., Li, S., Weng, C., Lin, M.-H., Ho, C., & Wu, M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.002 · Cited by 56 · see citing works
Iridoids and other monoterpenes in the Alzheimer’s brain: Recent development and future prospects
Habtemariam, S. (2018) · Molecules · doi:10.3390/molecules23010117 · Cited by 55 · see citing works
Wang, G., Wu, S., Xu, W., Jin, H. W., Zhu, Z., Li, Z., Tian, Y., Zhang, J., Rao, J.-J., & Wu, S. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.83 · Cited by 52 · see citing works
Protective Effects of Geniposide and Genipin against Hepatic Ischemia/Reperfusion Injury in Mice
Kim, J.-K., Kim, H.-Y., & Lee, S.-M. (2013) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2013.005 · Cited by 51 · see citing works
Xu, M., Wu, H., Liu, H., Gong, N., Wang, Y., & Wang, Y. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13720 · Cited by 52 · see citing works
Liu, J., Yin, F., Xiao, H., Guo, L., & Gao, X. C. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.07.004 · Cited by 49 · see citing works
Self-citationTherapeutic targets of brain insulin resistance in sporadic Alzheimer's disease
Suzanne, M. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/482 · Cited by 50 · see citing works
Mohsenpour, H., Pesce, M., Patruno, A., Bahrami, A., Pour, P. M., & Farzaei, M. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020833 · Cited by 48 · see citing works
Liu, H., He, J., Li, W., Zhu, Y., Wang, Y., Yin, J. J., Du, Y., & Yu, C. (2009) · Inflammation Research · doi:10.1007/s00011-009-0118-3 · Cited by 48 · see citing works
Zhang, Y., Yin, F., Liu, J., Liu, Z., Guo, L., Xia, Z., & Zidichouski, J. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.04.002 · Cited by 45 · see citing works
Self-citationZhang, Z., Li, Y., Shen, P. F., Li, S., Lu, X., Liu, J., Cao, Y., Liu, B., Fu, Y., & Zhang, N. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.033 · Cited by 46 · see citing works
Self-citationZhang, X., Liu, K., Shi, M., Xie, L., Deng, M., Chen, H., & Li, X. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.06.020 · Cited by 46 · see citing works
The emerging possibility of the use of geniposide in the treatment of cerebral diseases: a review
Zhang, W., Zhang, F., Hu, Q., Xiao, X., Ou, L., Chen, Y., Luo, S., Cheng, Y., Jiang, Y., Ma, X., et al. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00486-3 · Cited by 46 · see citing works
Zhou, Y., Men, L., Pi, Z., Wei, M., Song, F., Zhao, C., & Liu, Z. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b06082 · Cited by 43 · see citing works
Wang, L., Chen, S., Liu, S., Biu, A. M., Yu-li, H., Jin, X., Liang, C., Liu, Y., Li, J., Fang, S., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117397 · Cited by 42 · see citing works
Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
Groeneveld, O. N., Kappelle, L. J., & Biessels, G. J. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12420 · Cited by 41 · see citing works
Geniposide attenuates cadmium‑induced oxidative stress injury via Nrf2 signaling in osteoblasts
He, T., Shen, H., Zhu, J., Zhu, Y., He, Y., Li, Z., & Lu, H.-X. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10396 · Cited by 42 · see citing works
Chik, S. C. C., Or, T. C. T., Luo, D., Yang, C. L.-H., & Lau, A. S. Y. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/896873 · Cited by 41 · see citing works
Yin, F., Liu, J., Zheng, X., & Guo, L. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.28 · Cited by 41 · see citing works
Self-citationZhao, C., Lv, C., Li, H., Du, S., Liu, X., Li, Z., Xin, W., & Zhang, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152551 · Cited by 39 · see citing works
Tramutola, A., Arena, A., Cini, C., Butterfield, D. A., & Barone, E. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1246183 · Cited by 39 · see citing works
Cheng, F., Zhong, X., Lu, Y., Wang, X., Song, W., Guo, S., Wang, X., Liu, D., & Wang, Q. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/567872 · Cited by 37 · see citing works
Wang, R., Yang, J., Peng, L., Zhao, J., Mu, N., Huang, J., Lazarovici, P., Chen, H., & Zheng, W. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.056 · Cited by 36 · see citing works
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
Bak, A. M., Egefjord, L., Gejl, M., Steffensen, C., Stecher, C. W., Smidt, K., Brock, B., & Rungby, J. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.600691 · Cited by 36 · see citing works
Zhang, Y., Yin, F., Liu, J., & Liu, Z. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12673 · Cited by 34 · see citing works
Self-citationQi, Q., Mao, Y., Tian, Y., Zhu, K., Cha, X., Wu, M., & Zhou, X. (2017) · PubMed Central · Cited by 35 · see citing works
Glycosides for Peripheral Neuropathic Pain: A Potential Medicinal Components
Tian, M., Li, Y., Liu, S., Zhu, C., Lan, X., Du, J., Ma, L., Yang, J., Zheng, P., Yu, J., et al. (2021) · Molecules · doi:10.3390/molecules27010255 · Cited by 34 · see citing works
Liu, J., Guo, L., Yin, F., Zhang, Y., Liu, Z., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078315 · Cited by 34 · see citing works
Self-citationNeuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson’s Disease
Dong, D., Xie, J.-X., & Wang, J. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00407-3 · Cited by 34 · see citing works
Kimura, R., Okouchi, M., Kato, T., Imaeda, K., Okayama, N., Asai, K., & Joh, T. (2012) · Neuroendocrinology · doi:10.1159/000345529 · Cited by 33 · see citing works
Geniposide Suppresses Hepatic Glucose Production via AMPK in HepG2 Cells
Guo, L., Zheng, X., Liu, J., & Yin, Z. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00591 · Cited by 33 · see citing works
Self-citationYaribeygi, H., Farrokhi, F. R., Abdalla, M. A., Sathyapalan, T., Banach, M., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6518221 · Cited by 31 · see citing works
Geniposide decreases the level of Aβ1−42 in the hippocampus of streptozotocin-induced diabetic rats
Liu, J., Zhang, Y., Deng, X., & Yin, F. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt069 · Cited by 32 · see citing works
Self-citationAnti-hyperuricemic and nephroprotective effect of geniposide in chronic hyperuricemia mice
Liu, C., Zhou, H.-N., Zhang, R., Wang, X., He, S., Zhang, J., Guo, X., Wang, Q., & Sun, J. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.05.011 · Cited by 32 · see citing works
de la Monte, S. M. (2012) · Aging Health · doi:10.2217/ahe.11.89 · Cited by 31 · see citing works
Research and application progress of Gardenia jasminoides
Yin, F., & Liu, J. (2018) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2018.09.001 · Cited by 31 · see citing works
Self-citationLi, X., Ma, A., & Liu, K. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1601630 · Cited by 30 · see citing works
Coran, S. A., Mulas, S., & Vasconi, A. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.12.001 · Cited by 30 · see citing works
Mehan, S., Bhalla, S., Siddiqui, E. M., Sharma, N., Shandilya, A., & Khan, A. (2022) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s247153 · Cited by 29 · see citing works
Geniposide Alleviates Oxidative Damage in Hepatocytes through Regulating miR-27b-3p/Nrf2 Axis
Li, J., Ge, H., Xu, Y., Xie, J., Yan, F., & Chen, W. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c03856 · Cited by 26 · see citing works
Fusion of core pathways reveals a horizontal synergistic mechanism underlying combination therapy
Wang, Z., Jing, Z., Zhou, C., Zhang, L., Cheng, J., Zhang, Z., Liu, J. H., Xu, C., Li, P.-T., & Wang, Y.-Y. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.046 · Cited by 26 · see citing works
Self-citationCheng, F., Ma, C., Sun, L., Zhang, X., Zhai, C., Li, C., Zhang, S., Ren, B., Liu, S., Liu, S., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5395 · Cited by 25 · see citing works
Uneda, K., Kawai, Y., Yamada, T., Kaneko, A., Saito, R., Chen, L., Ishigami, T., Namiki, T., & MITSUMA, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266917 · Cited by 25 · see citing works
Zhang, G., Kim, S., Gu, X., Yu, S. P., & Wei, L. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00446-w · Cited by 25 · see citing works
Lx, G., Liu, H., & Yin, F. (2014) · PubMed · Cited by 24 · see citing works
Self-citationMechanisms for the anti-obesity actions of bofutsushosan in high-fat diet-fed obese mice
Kobayashi, S., Kawasaki, Y., Takahashi, T., Maeno, H., & Nomura, M. (2017) · Chinese Medicine · doi:10.1186/s13020-017-0129-x · Cited by 24 · see citing works
Liu, C.-Y., Hao, Y., Yin, F., Zhang, Y. L., & Liu, J. H. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0591-9 · Cited by 24 · see citing works
Self-citationKim, H. I., Hong, S. H., Ku, J. M., Kim, M.-J., Ju, S. W., Chang, S. W., Cheon, C., & Ko, S. (2020) · Nutrients · doi:10.3390/nu12010196 · Cited by 22 · see citing works
Wang, R., MoYung, K. C., Yj, Z., & Poon, K. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.15449 · Cited by 22 · see citing works
Liu, Z., Zhang, Y., Liu, J., & Yin, F. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0875-9 · Cited by 21 · see citing works
Self-citationBrown, S. B., Libonati, J. R., Selak, M. A., Shannon, R. P., & Simmons, R. A. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6242-z · Cited by 20 · see citing works
Guo, L., Liu, J. H., Zheng, X. X., Yin, Z., Kosaraju, J., & Tam, K. Y. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.03.038 · Cited by 20 · see citing works
Self-citationYe, J., Wu, J., Ai, L., Zhu, M., Li, Y., Yin, D., & Huang, Q. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116296 · Cited by 19 · see citing works
Yuan, Y., & Zheng, Z. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.11.047 · Cited by 18 · see citing works
RetractedLiu, C., Hao, Y., Yin, F., Zhang, Y., & Liu, J. (2017) · Cell Biology International · doi:10.1002/cbin.10758 · Cited by 18 · see citing works
Self-citationGál, A., Pentelényi, K., Reményi, V., Wappler-Guzzetta, E. A., Sáfrány, G., Skopál, J., & Nagy, Z. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.04.003 · Cited by 18 · see citing works
Barbieri, R., Alloisio, S., Ferroni, S., & Nobile, M. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.05.001 · Cited by 18 · see citing works
Genipin in an Ex Vivo Corneal Model of Bacterial and Fungal Keratitis
Koudouna, E., Huertas-Bello, M., Rodriguez, C. N., Riveros, S. C. H., Navarrete, M. L., & Avila, M. Y. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.9.31 · Cited by 17 · see citing works
Role of glucagon-like peptide- 1 in vascular endothelial dysfunction.
Goyal, S., Kumar, S., Bijjem, K. R. V., & Singh, M. (2010) · PubMed · Cited by 17 · see citing works
Cui, H., Deng, M., Zhang, Y., Yin, F., & Liu, J. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2469-z · Cited by 17 · see citing works
Self-citationLi, Y., Ba, M., Du, Y., Xia, C., Tan, S., Ng, K. P., & Ma, G. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119833742 · Cited by 17 · see citing works
Kioussis, B., Tuttle, C. S. L., Heard, D. S., Kennedy, B. K., Lautenschlager, N. T., & Maier, A. B. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101302 · Cited by 18 · see citing works
Huang, H., Zhang, X., Huang, Z., Zhang, Y., & Zhou, Z. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.4011 · Cited by 17 · see citing works
Che, X., Wang, M., Wang, T., Fan, H., Yang, M., Wang, W., & Xu, H. Z. (2016) · Molecules · doi:10.3390/molecules21070923 · Cited by 16 · see citing works
- Authors
- Liu, J., Yin, F., Zheng, X., Jing, J., & Hu, Y.
- Affiliations
- Chongqing Technology and Business University (CN)
- East China Normal University (CN)
- Corresponding author
- Liu, Jianhui
- ORCID
- Venue
- Neurochemistry International
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 51
- Issue
- 6-7
- Pages
- 361-369
- ISSN
- 0197-0186 (ISSN-L)
- OpenAlex
- W2069612190
- Cited by
- 145
- References
- 28
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 11 · 2020: 6 · 2019: 16 · 2018: 10 · 2017: 12 · 2016: 12 · 2015: 9 · 2014: 10 · 2013: 8 · 2012: 10
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurochemistry International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- geniposide, GLP-1 receptor agonists, Alzheimer's disease, oxidative stress, PC12 cells, MAPK signaling, p90RSK, Bcl-2, heme oxygenase-1, phosphatidylinositol 3-kinase, MEK, hydrogen peroxide, neuroprotection, neuronal differentiation
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Alzheimer Disease, Animals, Brain, Enzyme Inhibitors, Hydrogen Peroxide, Neurons, Phosphorylation, Pyrans, PC12 Cells, Receptors, Glucagon, Oxidative Stress, Neuroprotective Agents, Proto-Oncogene Proteins c-bcl-2, Proto-Oncogene Proteins c-raf, MAP Kinase Kinase Kinases, MAP Kinase Signaling System, Ribosomal Protein S6 Kinases, 90-kDa, Iridoids, Apoptosis Regulatory Proteins, Rats, Heme Oxygenase-1, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review